India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks
Tuesday, 22 September 2020
Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy`s, told Reuters.
💡 One News Page Knowledge: Other News Mentions
Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteersThe Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug..
Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines
Credit: HT Digital Content Duration: 05:47Published
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in IndiaAfter the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian..
Covid update: N95 mask export allowed; India ranks 4th; festival guidelines
Credit: HT Digital Content Duration: 03:14Published
You Might Like
Related videos from verified sources
Related news from verified sources
Tweets about this